Draper Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Draper Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,500	Closed	-$2.87M	–	45
2025 Q2	$2.87M	Buy	6,500 +69	+1%	+$31.8K	1.87%	9
2025 Q1	$3.12M	Buy	6,431 +98	+2%	+$45.7K	2.43%	9
2024 Q4	$2.6M	Buy	6,333 +33	+0.5%	+$15.3K	1.63%	10
2024 Q3	$2.93M	Buy	6,300 +618	+11%	+$297K	2.1%	9
2024 Q2	$2.66M	Buy	5,682 +96	+2%	+$41.7K	2.02%	9
2024 Q1	$2.3M	Buy	5,586 +10	+0.2%	+$4.23K	2%	9
2023 Q4	$2.27M	Buy	5,576 +13	+0.2%	+$4.8K	2.14%	9
2023 Q3	$1.93M	Buy	5,563 +657	+13%	+$230K	2.05%	9
2023 Q2	$1.73M	Buy	+4,906	New	+$1.65M	1.72%	9

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Draper Asset Management's VRTX Position: Q3 2025 in Review

Draper Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 6,500 shares — an estimated $2.87M sold.

Draper Asset Management first reported a position in VRTX in Q2 2023 and held it in 9 quarters. The position peaked at $3.12M in Q1 2025. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

Draper Asset Management reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Draper Asset Management sold 6,500 Vertex Pharmaceuticals shares in Q3 2025, an estimated $2.87M.
Draper Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2023 and held it in 9 quarters.
Draper Asset Management's Vertex Pharmaceuticals position peaked at $3.12M in Q1 2025.
1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Draper Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.